These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35908385)

  • 1. Increased expression of ST2 on regulatory T cells is associated with cancer associated fibroblast-derived IL-33 in laryngeal cancer.
    Zhao Y; Sun J; Liang Y; Jiang X; Tang X; Sun Y; Xu C; Wan G; Sun J; Pan C
    Pathol Res Pract; 2022 Sep; 237():154023. PubMed ID: 35908385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
    Cui G; Li Z; Ren J; Yuan A
    Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
    Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
    Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
    Landskron G; De la Fuente López M; Dubois-Camacho K; Díaz-Jiménez D; Orellana-Serradell O; Romero D; Sepúlveda SA; Salazar C; Parada-Venegas D; Quera R; Simian D; González MJ; López-Köstner F; Kronberg U; Abedrapo M; Gallegos I; Contreras HR; Peña C; Díaz-Araya G; Roa JC; Hermoso MA
    Front Immunol; 2019; 10():1394. PubMed ID: 31281317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
    Cui G; Yuan A; Li Z; Goll R; Florholmen J
    Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ST2
    Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
    Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33/ST2 Axis Protects Against Traumatic Brain Injury Through Enhancing the Function of Regulatory T Cells.
    Xie D; Miao W; Xu F; Yuan C; Li S; Wang C; Junagade A; Hu X
    Front Immunol; 2022; 13():860772. PubMed ID: 35432343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
    Son J; Cho JW; Park HJ; Moon J; Park S; Lee H; Lee J; Kim G; Park SM; Lira SA; Mckenzie AN; Kim HY; Choi CY; Lim YT; Park SY; Kim HR; Park SH; Shin EC; Lee I; Ha SJ
    Cancer Immunol Res; 2020 Nov; 8(11):1393-1406. PubMed ID: 32878747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
    Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
    PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
    Lei S; Jin J; Zhao X; Zhou L; Qi G; Yang J
    Exp Biol Med (Maywood); 2022 Oct; 247(20):1810-1818. PubMed ID: 35733343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8
    Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F
    Front Immunol; 2018; 9():1179. PubMed ID: 29896199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
    Matta BM; Reichenbach DK; Zhang X; Mathews L; Koehn BH; Dwyer GK; Lott JM; Uhl FM; Pfeifer D; Feser CJ; Smith MJ; Liu Q; Zeiser R; Blazar BR; Turnquist HR
    Blood; 2016 Jul; 128(3):427-39. PubMed ID: 27222477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development.
    Li A; Herbst RH; Canner D; Schenkel JM; Smith OC; Kim JY; Hillman M; Bhutkar A; Cuoco MS; Rappazzo CG; Rogers P; Dang C; Jerby-Arnon L; Rozenblatt-Rosen O; Cong L; Birnbaum M; Regev A; Jacks T
    Cell Rep; 2019 Dec; 29(10):2998-3008.e8. PubMed ID: 31801068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis.
    Andersson P; Yang Y; Hosaka K; Zhang Y; Fischer C; Braun H; Liu S; Yu G; Liu S; Beyaert R; Chang M; Li Q; Cao Y
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obese visceral adipose dendritic cells downregulate regulatory T cell development through IL-33.
    Soedono S; Sharlene S; Vo DHN; Averia M; Rosalie EE; Lee YK; Cho KW
    Front Immunol; 2024; 15():1335651. PubMed ID: 38566998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.
    Chen L; Wang G; Qiao X; Wang X; Liu J; Niu X; Zhong M
    Med Sci Monit; 2020 Jan; 26():e921863. PubMed ID: 31990904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma.
    Rasheed K; Moens U; Policastro B; Johnsen JI; Koljonen V; Sihto H; Lui WO; Sveinbjørnsson B
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.